“massachusetts-general-hospital” Archives

in
Entry Author Date Location
StartingBlock, Cellectar & 500 Startups: This Week’s WI Watchlist 05/20/16 Wisconsin
MGH Goes Epic: What I Learned in the Trenches 05/10/16 Boston
From Alexa to Watson, Boston Children’s Hospital Ups Digital Focus 03/30/16 Boston
Boston Tech Watch: Telehealth, Fantasy Sports, Cleantech, More 02/29/16 Boston
Atlas5D Snags $3M For Sensor Devices That Balance Data & Privacy 02/01/16 Boston
Depression Trials Fail, Alkermes Sees Silver Lining. Investors Don’t. 01/21/16 Boston
Amid Neuroscience Renaissance, BlackThorn Quietly Builds a Business 12/23/15 San Francisco
NinePoint, Under New Leadership, Bags $31M More For Imaging Tech 11/30/15 Boston
Big Bucks, Tiny Bubbles: Ex-Biogen Exec’s Exosome Startup Nabs $80M 11/17/15 Boston
Taris 2.0: A Year After Buyout, VCs Bet $32M More on a Second Strike 10/27/15 Boston
Cancer Vaccines Back in Vogue as VCs Put $102M Into Gritstone Oncology 10/20/15 San Francisco
With PCSK9’s Origins In Mind, Sanofi Has UT Join Funding Program 07/09/15 Texas
XTuit Gets $22M From NEA, Polaris to Battle Cancer, Liver Disease 06/11/15 Boston
ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer 04/21/15 Boston
Biotech M&A by Slow Simmer: An Inside Look at the Build to Buy Deal 02/18/15 New York
Ready, Aim, CRISPR: Will Gene-Editing Tools Hit Their Targets? 02/17/15 National
Exosome Dx, Aiming to Commercialize “Liquid Biopsies,” Seeks $25M 01/28/15 Boston
Intrigue and Outdated Rules Complicate Big Biotech Patent Fight 12/16/14 National
Famed Geneticist Altshuler Bolts Broad Institute for Vertex 12/15/14 Boston
After Spinning Onyx into Gold, Coles Returns to Lead a CNS Startup 12/15/14 Boston
After Unlikely Idenix Sale, Renaud Jumps to RaNA to Outfox Junk DNA 12/01/14 Boston
MassChallenge Winner From MIT Aims to Kill Cancer With a “Squeeze” 11/24/14 Boston
RetroSense Closer to Clinical Trials After Orphan Drug Designation 11/05/14 Detroit Ann Arbor
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors 10/14/14 Boston
With FDA Nod, T2 Bio’s Sepsis Test Heads to Commercial Proving Ground 09/23/14 Boston
With $32M, Boston Anti-Fungal Startup Morphs Into San Diego’s Cidara 06/30/14 San Diego
Katrine Bosley, Former Avila CEO, Takes Helm at Editas 06/24/14 Boston
Rodin Moves From Seedling to Neurology Startup With $12.9M Series A 05/29/14 Boston
QPID Health Raises $12M to Expand Medical Record Search Software 05/06/14 Boston
Page 1 of 5 next page »